GABAergic function in detoxified heroin addicts: relationship to anxiety disorders. (Q52275879)

28 April 2018

title

GABAergic function in detoxified heroin addicts: relationship to anxiety disorders. (English)

1 reference

28 April 2018

author name string

Gerra G

1

1 reference

28 April 2018

Ferri M

2

1 reference

28 April 2018

Zaimovic A

3

1 reference

28 April 2018

Giucastro G

4

1 reference

28 April 2018

Palladino M

5

1 reference

28 April 2018

Sartori R

6

1 reference

28 April 2018

Delsignore R

7

1 reference

28 April 2018

Maestri D

8

1 reference

28 April 2018

Marzocchi G

9

1 reference

28 April 2018

Brambilla F

10

1 reference

28 April 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

28 April 2018

published in

Psychiatry Research

1 reference

28 April 2018

volume

77

1 reference

28 April 2018

issue

2

1 reference

28 April 2018

page(s)

89-96

1 reference

28 April 2018

GABAA and GABAB antagonists prevent the opioid inhibition of endogenous acetylcholine release evoked by glutamate from rat neostriatal slices

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Intravenous sodium lactate decreases plasma GABA levels in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Lack of tolerance in heroin-addicts to the neuroendocrine effects of an enkephalin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Naloxone does not alter the effect of gamma aminobutyric acid derivative, baclofen, on GH release in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Role of the amygdala and periaqueductal gray in anxiety and panic

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Anxiety or depression during withdrawal of hypnotic treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

The growth hormone response to baclofen in obsessive compulsive disorder: does the GABA-B receptor mediate obsessive anxiety?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Vulnerability to substance abuse and psychopathology among siblings of opioid abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Psychopathology among substance abusing juvenile offenders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Social phobia and clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

GABA and baclofen potentiate the K+-evoked release of methionine-enkephalin from rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

Activation of GABA receptors in the hypothalamus stimulates secretion of growth hormone and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2897%2900147-9

7 January 2021

10.1016/S0165-1781(97)00147-9

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018